These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11877294)

  • 41. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells.
    Chatterjee M; Stühmer T; Herrmann P; Bommert K; Dörken B; Bargou RC
    Blood; 2004 Dec; 104(12):3712-21. PubMed ID: 15297310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling.
    Irie-Sasaki J; Sasaki T; Matsumoto W; Opavsky A; Cheng M; Welstead G; Griffiths E; Krawczyk C; Richardson CD; Aitken K; Iscove N; Koretzky G; Johnson P; Liu P; Rothstein DM; Penninger JM
    Nature; 2001 Jan; 409(6818):349-54. PubMed ID: 11201744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effects of interleukin-3 and interleukin-1 on the proliferation and interleukin-6 protein secretion of acute myeloid leukemic cells; the involvement of ERK, p38 and STAT5.
    Birkenkamp KU; Esselink MT; Kruijer W; Vellenga E
    Eur Cytokine Netw; 1999 Dec; 10(4):479-90. PubMed ID: 10586114
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis.
    Giuliani N; Lunghi P; Morandi F; Colla S; Bonomini S; Hojden M; Rizzoli V; Bonati A
    Leukemia; 2004 Mar; 18(3):628-35. PubMed ID: 14737074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A role for the extracellular signal-regulated kinase and p38 mitogen-activated protein kinases in interleukin-1 beta-stimulated delayed signal tranducer and activator of transcription 3 activation, atrial natriuretic factor expression, and cardiac myocyte morphology.
    Ng DC; Long CS; Bogoyevitch MA
    J Biol Chem; 2001 Aug; 276(31):29490-8. PubMed ID: 11382751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of interleukin 6 (IL-6)/IL-6R-induced signal tranducers and activators of transcription and mitogen-activated protein kinase/extracellular.
    Legendre F; Bogdanowicz P; Boumediene K; Pujol JP
    J Rheumatol; 2005 Jul; 32(7):1307-16. PubMed ID: 15996070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phosphorylation of extracellular signal-regulated kinase 1 and 2, protein kinase B, and signal transducer and activator of transcription 3 are differently inhibited by an epidermal growth factor receptor inhibitor, EKB-569, in tumor cells and normal human keratinocytes.
    Nunes M; Shi C; Greenberger LM
    Mol Cancer Ther; 2004 Jan; 3(1):21-7. PubMed ID: 14749472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway.
    Tan J; Town T; Mullan M
    J Biol Chem; 2000 Nov; 275(47):37224-31. PubMed ID: 10978311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-gamma production by the stress kinase p38 and by the extracellular regulated kinases p44erk-1 and p42erk-21.
    Kalina U; Kauschat D; Koyama N; Nuernberger H; Ballas K; Koschmieder S; Bug G; Hofmann WK; Hoelzer D; Ottmann OG
    J Immunol; 2000 Aug; 165(3):1307-13. PubMed ID: 10903731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The involvement of PI 3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interleukin-6.
    Kuo ML; Chuang SE; Lin MT; Yang SY
    Oncogene; 2001 Feb; 20(6):677-85. PubMed ID: 11314001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses.
    Tu Y; Gardner A; Lichtenstein A
    Cancer Res; 2000 Dec; 60(23):6763-70. PubMed ID: 11118064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell lines.
    Hallek M; Neumann C; Schäffer M; Danhauser-Riedl S; von Bubnoff N; de Vos G; Druker BJ; Yasukawa K; Griffin JD; Emmerich B
    Exp Hematol; 1997 Dec; 25(13):1367-77. PubMed ID: 9406996
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation.
    Bellido T; Borba VZ; Roberson P; Manolagas SC
    Endocrinology; 1997 Sep; 138(9):3666-76. PubMed ID: 9275051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of JAK-STAT pathway is required for platelet-derived growth factor-induced proliferation of pancreatic stellate cells.
    Masamune A; Satoh M; Kikuta K; Suzuki N; Shimosegawa T
    World J Gastroenterol; 2005 Jun; 11(22):3385-91. PubMed ID: 15948243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An activated JAK/STAT3 pathway and CD45 expression are associated with sensitivity to Hsp90 inhibitors in multiple myeloma.
    Lin H; Kolosenko I; Björklund AC; Protsyuk D; Österborg A; Grandér D; Tamm KP
    Exp Cell Res; 2013 Mar; 319(5):600-11. PubMed ID: 23246572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of IL-6-mediated growth control of myeloma cells using a gp130 chimeric receptor approach.
    French JD; Tschumper RC; Jelinek DF
    Leukemia; 2002 Jun; 16(6):1189-96. PubMed ID: 12040452
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Directly linked soluble IL-6 receptor-IL-6 fusion protein induces astrocyte differentiation from neuroepithelial cells via activation of STAT3.
    Takizawa T; Yanagisawa M; Ochiai W; Yasukawa K; Ishiguro T; Nakashima K; Taga T
    Cytokine; 2001 Mar; 13(5):272-9. PubMed ID: 11243705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Signal transduction pathways of IL-1beta-mediated iNOS in pulmonary vascular smooth muscle cells.
    Finder JD; Petrus JL; Hamilton A; Villavicencio RT; Pitt BR; Sebti SM
    Am J Physiol Lung Cell Mol Physiol; 2001 Oct; 281(4):L816-23. PubMed ID: 11557585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.